Synthesis and in vitro Anticancer Activity of Ruthenium-Cymene Complexes with Cyclohexyl-Functionalized Ethylenediamine-N,N′-diacetate-Type Ligands
Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterizat...
Saved in:
Published in | ChemMedChem Vol. 6; no. 10; pp. 1884 - 1891 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
04.10.2011
WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC50: 1.0–20.2 μM), with the n‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of RuII‐based compounds.
Mitochondria depolarized! Novel ruthenium(II) arene complexes containing alkyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid as chelating agents show potent selective antitumor activity. They induce apoptosis via a mitochondrial pathway involving mechanisms different from those induced by platinum‐based drugs. |
---|---|
AbstractList | Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and n‐butyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1H, and 13C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC50: 1.0–20.2 μM), with the n‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of RuII‐based compounds.
Mitochondria depolarized! Novel ruthenium(II) arene complexes containing alkyl esters of (S,S)‐ethylenediamine‐N,N′‐di‐2‐(3‐cyclohexyl)propanoic acid as chelating agents show potent selective antitumor activity. They induce apoptosis via a mitochondrial pathway involving mechanisms different from those induced by platinum‐based drugs. Herein we describe the synthesis, characterization, and anticancer activity of novel p-cymeneruthenium(II) complexes containing methyl, ethyl, n-propyl, and n-butyl esters of (S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, (1)H, and (13)C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL-60, K562, and REH cells (IC(50): 1.0-20.2 μM), with the n-butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n-butyl ester complex is more effective against leukemic patients' blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of Ru(II)-based compounds. Abstract Herein we describe the synthesis, characterization, and anticancer activity of novel p ‐cymeneruthenium(II) complexes containing methyl, ethyl, n ‐propyl, and n ‐butyl esters of ( S , S )‐ethylenediamine‐ N , N′ ‐di‐2‐(3‐cyclohexyl)propanoic acid. The results of IR, UV/Vis, ESIMS, 1 H, and 13 C NMR characterization reveal that ligand coordination occurs through nitrogen donor atoms of the ester ligands, with the organoruthenium moiety being kept in complex. These ruthenium(II) complexes are cytotoxic toward various cancer cell lines including leukemic HL‐60, K562, and REH cells (IC 50 : 1.0–20.2 μ M ), with the n ‐butyl ester complex being the most effective. It causes apoptotic cell death associated with mitochondrial depolarization, caspase activation, phosphatidylserine exposure, and DNA fragmentation. Importantly, the n ‐butyl ester complex is more effective against leukemic patients′ blood mononuclear cells relative to those from healthy control subjects, thus indicating a fairly selective antileukemic action of Ru II ‐based compounds. |
Author | Misirlić-Denčić, Sonja Jovanović, Maja Trajković, Vladimir Dulović, Marija Sabo, Tibor J. Marković, Ivanka Poljarević, Jelena M. Bogdanović, Andrija Savić, Aleksandar Grgurić-Šipka, Sanja |
Author_xml | – sequence: 1 givenname: Aleksandar surname: Savić fullname: Savić, Aleksandar organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia) – sequence: 2 givenname: Marija surname: Dulović fullname: Dulović, Marija organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia) – sequence: 3 givenname: Jelena M. surname: Poljarević fullname: Poljarević, Jelena M. organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia) – sequence: 4 givenname: Sonja surname: Misirlić-Denčić fullname: Misirlić-Denčić, Sonja organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia) – sequence: 5 givenname: Maja surname: Jovanović fullname: Jovanović, Maja organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia) – sequence: 6 givenname: Andrija surname: Bogdanović fullname: Bogdanović, Andrija organization: Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr. Koste Todorovića 2, 11000 Belgrade (Serbia) – sequence: 7 givenname: Vladimir surname: Trajković fullname: Trajković, Vladimir organization: Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Dr. Subotića 1, 11000 Belgrade (Serbia) – sequence: 8 givenname: Tibor J. surname: Sabo fullname: Sabo, Tibor J. organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia) – sequence: 9 givenname: Sanja surname: Grgurić-Šipka fullname: Grgurić-Šipka, Sanja email: sanjag@chem.bg.ac.rs organization: Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade (Serbia) – sequence: 10 givenname: Ivanka surname: Marković fullname: Marković, Ivanka email: ivanka@med.bg.ac.rs organization: Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade (Serbia) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21805645$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc2O0zAQxy20iP2AK0fkGxdcbMdOnGOV_YBSirQscLS89pQaEqfEDttw2gvPwHvwSPskpOpSceM0M9bv95c1c4wOQhsAoaeMThil_KVtnJ1wyrZDxh-gI6ZySgqmioN9X5SH6DjGL5QKoZh6hA45U1TmQh6hX--HkFYQfcQmOOzD3e3P7z51LZ6G5K0JFjo8tcmPjwNul_iyH_Hg-4ZUQwMBcNU26xo2EPGNTytcDbZuV7AZanLeh1Fsg6n9D3D4LK2GejScN40PQBYvFne3v8k4WkgmAbka1oDn_vP4kfgYPVyaOsKT-3qCPpyfXVWvyPzdxetqOic2Y5yTXMmy4O6a01yWUMhSCmeMyuUShFvmLJPUZQBKGCcEZ4KWKs-kKilQJZyj2Ql6vstdd-23HmLSjY8W6toEaPuoVSmVlEXBR3KyI23XxtjBUq8735hu0Izq7fr19hZ6f4tReHYf3V834Pb43-WPQLkDbnwNw3_idPX2tPo3nOxcHxNs9q7pvuq8yAqpPy0u9OxSfZyV8zd6lv0Breuq3A |
CitedBy_id | crossref_primary_10_1149_2_1121810jes crossref_primary_10_1002_aoc_3401 crossref_primary_10_1021_acs_jced_2c00318 crossref_primary_10_1007_s11094_015_1184_1 crossref_primary_10_1016_j_leukres_2015_06_013 crossref_primary_10_1039_C7NJ04416J crossref_primary_10_1016_j_ccr_2014_08_002 crossref_primary_10_1080_00958972_2017_1282611 crossref_primary_10_1021_ic500825j crossref_primary_10_1016_j_ica_2022_120797 crossref_primary_10_1016_j_jinorgbio_2013_08_002 crossref_primary_10_2174_0929867325666181031114306 crossref_primary_10_3390_inorganics11120460 crossref_primary_10_1016_j_ijbiomac_2012_01_030 crossref_primary_10_1016_j_jorganchem_2013_08_041 crossref_primary_10_1021_acs_organomet_5b00041 crossref_primary_10_1016_j_jorganchem_2016_06_024 crossref_primary_10_1016_j_ejmech_2014_05_060 crossref_primary_10_1002_open_202200019 |
Cites_doi | 10.1006/abio.1996.0383 10.1038/nrm1496 10.1007/s00432-004-0617-0 10.1021/jm010051m 10.1006/excr.2000.4833 10.1021/bi034933u 10.1073/pnas.0800076105 10.1002/ijc.21080 10.1016/S0010-8545(02)00025-5 10.1016/0020-1693(94)04159-8 10.1002/cmdc.201000058 10.1002/chem.200600110 10.1016/j.biochi.2009.03.017 10.1021/ja027719m 10.1016/0065-2571(84)90007-4 10.1002/chem.200304724 10.1039/c0sc00175a 10.1039/b905798f 10.1002/asia.200800149 10.1084/jem.182.5.1545 10.1016/j.jinorgbio.2010.05.002 10.1021/ic50211a024 10.1146/annurev.biochem.68.1.383 10.1016/S0022-328X(97)00776-6 10.1039/B712656P 10.1039/b508531b 10.1039/b904071d 10.1016/j.drup.2006.05.002 10.1046/j.1432-1327.2000.01121.x 10.1016/j.molmed.2006.07.007 10.1016/j.jinorgbio.2006.02.013 |
ContentType | Journal Article |
Copyright | Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
Copyright_xml | – notice: Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim – notice: Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/cmdc.201100232 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1860-7187 |
EndPage | 1891 |
ExternalDocumentID | 10_1002_cmdc_201100232 21805645 CMDC201100232 ark_67375_WNG_JR8VJ9LK_J |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministry of Science of the Republic of Serbia funderid: 41025; 172035 |
GroupedDBID | --- 05W 0R~ 1L6 1OC 29B 33P 3WU 4.4 53G 5GY 66C 6J9 77Q 8-0 8-1 A00 AAESR AAHHS AANLZ AASGY AAXRX AAZKR ABCUV ABIJN ABJNI ABLJU ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFRAH AHBTC AHMBA AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI BSCLL CS3 DCZOG DR2 DRFUL DRSTM DU5 EBS EJD F5P FEDTE G-S GODZA HBH HGLYW HHZ HVGLF HZ~ IX1 LATKE LAW LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MXFUL MXSTM MY~ O9- OIG P2W P4E PQQKQ ROL RWI SUPJJ W99 WBKPD WXSBR WYJ XV2 YZZ ZZTAW ~S- CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3122-685972db20659e75954daa865fe4df61350d3ee84ad44214098635890e084dd03 |
IEDL.DBID | DR2 |
ISSN | 1860-7179 |
IngestDate | Thu Jul 25 09:37:13 EDT 2024 Fri Aug 23 01:12:01 EDT 2024 Sat Sep 28 07:48:54 EDT 2024 Sat Aug 24 00:52:57 EDT 2024 Wed Oct 30 09:58:20 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3122-685972db20659e75954daa865fe4df61350d3ee84ad44214098635890e084dd03 |
Notes | istex:C8959A8351211DA42277CFE9523F5877A0449389 ark:/67375/WNG-JR8VJ9LK-J ArticleID:CMDC201100232 Ministry of Science of the Republic of Serbia - No. 41025; No. 172035 These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21805645 |
PQID | 895855772 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_895855772 crossref_primary_10_1002_cmdc_201100232 pubmed_primary_21805645 wiley_primary_10_1002_cmdc_201100232_CMDC201100232 istex_primary_ark_67375_WNG_JR8VJ9LK_J |
PublicationCentury | 2000 |
PublicationDate | 2011-10-04 October 4, 2011 2011-Oct-04 20111004 |
PublicationDateYYYYMMDD | 2011-10-04 |
PublicationDate_xml | – month: 10 year: 2011 text: 2011-10-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | Weinheim |
PublicationPlace_xml | – name: Weinheim – name: Germany |
PublicationTitle | ChemMedChem |
PublicationTitleAlternate | ChemMedChem |
PublicationYear | 2011 |
Publisher | WILEY-VCH Verlag WILEY‐VCH Verlag |
Publisher_xml | – name: WILEY-VCH Verlag – name: WILEY‐VCH Verlag |
References | M. J. Clarke, Coord. Chem. Rev. 2002, 232, 69-93. C. G. Hartinger, S. Zorbas-Seifried, M. A. Jakupec, B. Kynast, H. Zorbas, B. K. Keppler, J. Inorg. Biochem. 2006, 100, 891-904. T. T. Yang, P. Sinai, S. R. Kain, Anal. Biochem. 1996, 241, 103-108. V. Brabec, O. Nováková, Drug Resist. Updates 2006, 9, 111-22. R. A. Vilaplana, F. Gonzalez-Vilchez, E. Gutierrez-Puebla, C. Ruiz-Valero, Inorg. Chim. Acta 1994, 224, 15-18. S. Dougan, A. Habtemariam, S. McHale, S. Parsons, P. Sadler, P. Natl. Acad. Sci. USA 2008, 105, 11628-11633. W. C. Earnshaw, L. M. Martins, S. H. Kaufmann, Annu. Rev. Biochem. 1999, 68, 383-424. H. K. Liu, F. Wang, J. A. Parkinson, J. Bella, P. J. Sadler, Chem. Eur. J. 2006, 12, 6151-6165. A. Pizarro, P. Sadler, Biochimie 2009, 91, 1198-1211. H. Chen, J. A. Parkinson, R. E. Morris, P. J. Sadler, J. Am. Chem. Soc. 2003, 125, 173-186. T. C. Chou, P. Talalay, Adv. Enzyme Regul. 1984, 22, 27-55. Y. K. Yan, M. Melchart, A. Habtemariam, P. Sadler, Chem. Commun. 2005, 4764-4776. J. M. Lazić, L. Vučićević, S. Grgurić-Šipka, K. Janjetović, G. Kaluderović, M. Misirkić, M. Gruden-Pavlović, D. Popadić, R. Paschke, V. Trajković, T. Sabo, ChemMedChem 2010, 5, 881-889. M. Loeffler, G. Kroemer, Exp. Cell Res. 2000, 256, 19-26. M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger, B. K. Keppler, Dalton Trans. 2008, 183-194. F. Wang, H. Chen, S. Parsons, I. Oswald, J. E. Davidson, P. J. Sadler, Chem. Eur. J. 2003, 9, 5810-5820. World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (Eds: S. H. Swerdlow, E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, J. W. Vardiman) IARC Press, Lyon, 2008. A. Martínez, C. Rajapakse, R. A. Sánchez-Delgado, A. Varela-Ramirez A, C. Lema, R. J. R. J. Aguilera, J. Inorg. Biochem. 2010, 104, 967-977. R. A. Krause, K. Krause, Inorg. Chem. 1980, 19, 2600-2603. L. Messori, P. Orioli, D. Vullo, E. Alessio, E. Iengo, Eur. J. Biochem. 2000, 267, 1206-1213. W. P. Roos, B. Kaina, Trends Mol. Med. 2006, 12, 440-50. O. Nováková, H. Chen, O. Vrana, A. Rodger, P. J. Sadler, V. Brabec, Biochemistry 2003, 42, 11544-11554. S. Kapitza, M. Pongratz, M. A. Jakupec, P. Heffeter, W. Berger, L. Lackinger, B. K. Keppler, B. Marian, J. Cancer Res. Clin. Oncol. 2005, 131, 101-110. R. E. Morris, R. E. Aird, P. Murdoch, H. Chen, J. Cummings, N. D. Hughes, S. Parsons, A. Parkin, G. Boyd, D. Jodrell, P. J. Sadler, J. Med. Chem. 2001, 44, 3616-3621. H. Liu, J. A. Parkinson, J. Bella, F. Wang, P. J. Sadler, Chem. Sci. 2010, 1, 258-270. T. Gianferrara, I. Bratsos, E. Alessio, Dalton Trans. 2009, 7588-7598. S. B. Jensen, S. J. Rodger, M. D. Spicer, J. Organomet. Chem. 1998, 556, 151-158. A. Levina, A. Mitra, P. A. Lay, Metallomics 2009, 1, 458-470. S. J. Martin, C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, D. R. Green, J. Exp. Med. 1995, 182, 1545-1556. S. Riedl, Y. Shi, Nat. Rev. Mol. Cell Biol. 2004, 5, 897-907. G. N. Kaludjerović, D. Miljković, M. Momčilović, V. M. Djinović, M. Mostarica Stojković, T. J. Sabo, V. Trajković, Int. J. Cancer 2005, 116, 479-486. A. F. A. Peacock, P. J. Sadler, Chem. Asian J. 2008, 3, 1890-1899. 2005; 131 2006; 12 2000; 256 2010; 104 1984; 22 2002; 232 2006; 9 2005; 116 2009 1999; 68 2008 2004; 5 2005 2008; 105 2008; 3 1996; 241 1998; 556 2001; 44 1980; 19 1994; 224 2010; 1 2000; 267 2009; 91 2003; 9 2003; 125 2009; 1 2010; 5 2003; 42 1995; 182 2006; 100 e_1_2_6_31_2 e_1_2_6_30_2 e_1_2_6_18_2 e_1_2_6_19_2 e_1_2_6_12_2 e_1_2_6_13_2 e_1_2_6_10_2 e_1_2_6_11_2 e_1_2_6_32_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_1_2 e_1_2_6_21_2 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 (e_1_2_6_29_2) 2008 e_1_2_6_25_2 |
References_xml | – volume: 42 start-page: 11544 year: 2003 end-page: 11554 publication-title: Biochemistry – volume: 1 start-page: 458 year: 2009 end-page: 470 publication-title: Metallomics – volume: 3 start-page: 1890 year: 2008 end-page: 1899 publication-title: Chem. Asian J. – volume: 232 start-page: 69 year: 2002 end-page: 93 publication-title: Coord. Chem. Rev. – volume: 5 start-page: 881 year: 2010 end-page: 889 publication-title: ChemMedChem – volume: 131 start-page: 101 year: 2005 end-page: 110 publication-title: J. Cancer Res. Clin. Oncol. – volume: 100 start-page: 891 year: 2006 end-page: 904 publication-title: J. Inorg. Biochem. – volume: 241 start-page: 103 year: 1996 end-page: 108 publication-title: Anal. Biochem. – volume: 44 start-page: 3616 year: 2001 end-page: 3621 publication-title: J. Med. Chem. – start-page: 7588 year: 2009 end-page: 7598 publication-title: Dalton Trans. – volume: 12 start-page: 6151 year: 2006 end-page: 6165 publication-title: Chem. Eur. J. – volume: 9 start-page: 111 year: 2006 end-page: 22 publication-title: Drug Resist. Updates – volume: 9 start-page: 5810 year: 2003 end-page: 5820 publication-title: Chem. Eur. J. – volume: 182 start-page: 1545 year: 1995 end-page: 1556 publication-title: J. Exp. Med. – volume: 556 start-page: 151 year: 1998 end-page: 158 publication-title: J. Organomet. Chem. – volume: 19 start-page: 2600 year: 1980 end-page: 2603 publication-title: Inorg. Chem. – volume: 267 start-page: 1206 year: 2000 end-page: 1213 publication-title: Eur. J. Biochem. – volume: 68 start-page: 383 year: 1999 end-page: 424 publication-title: Annu. Rev. Biochem. – start-page: 4764 year: 2005 end-page: 4776 publication-title: Chem. Commun. – year: 2008 – volume: 125 start-page: 173 year: 2003 end-page: 186 publication-title: J. Am. Chem. Soc. – start-page: 183 year: 2008 end-page: 194 publication-title: Dalton Trans. – volume: 105 start-page: 11628 year: 2008 end-page: 11633 publication-title: P. Natl. Acad. Sci. USA – volume: 1 start-page: 258 year: 2010 end-page: 270 publication-title: Chem. Sci. – volume: 116 start-page: 479 year: 2005 end-page: 486 publication-title: Int. J. Cancer – volume: 224 start-page: 15 year: 1994 end-page: 18 publication-title: Inorg. Chim. Acta – volume: 91 start-page: 1198 year: 2009 end-page: 1211 publication-title: Biochimie – volume: 104 start-page: 967 year: 2010 end-page: 977 publication-title: J. Inorg. Biochem. – volume: 256 start-page: 19 year: 2000 end-page: 26 publication-title: Exp. Cell Res. – volume: 5 start-page: 897 year: 2004 end-page: 907 publication-title: Nat. Rev. Mol. Cell Biol. – volume: 12 start-page: 440 year: 2006 end-page: 50 publication-title: Trends Mol. Med. – volume: 22 start-page: 27 year: 1984 end-page: 55 publication-title: Adv. Enzyme Regul. – ident: e_1_2_6_30_2 doi: 10.1006/abio.1996.0383 – ident: e_1_2_6_23_2 doi: 10.1038/nrm1496 – ident: e_1_2_6_27_2 doi: 10.1007/s00432-004-0617-0 – ident: e_1_2_6_13_2 doi: 10.1021/jm010051m – ident: e_1_2_6_26_2 doi: 10.1006/excr.2000.4833 – ident: e_1_2_6_17_2 doi: 10.1021/bi034933u – volume-title: World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues year: 2008 ident: e_1_2_6_29_2 – ident: e_1_2_6_9_2 doi: 10.1073/pnas.0800076105 – ident: e_1_2_6_31_2 doi: 10.1002/ijc.21080 – ident: e_1_2_6_7_2 doi: 10.1016/S0010-8545(02)00025-5 – ident: e_1_2_6_5_2 doi: 10.1016/0020-1693(94)04159-8 – ident: e_1_2_6_16_2 doi: 10.1002/cmdc.201000058 – ident: e_1_2_6_18_2 doi: 10.1002/chem.200600110 – ident: e_1_2_6_12_2 doi: 10.1016/j.biochi.2009.03.017 – ident: e_1_2_6_15_2 doi: 10.1021/ja027719m – ident: e_1_2_6_32_2 doi: 10.1016/0065-2571(84)90007-4 – ident: e_1_2_6_11_2 doi: 10.1002/chem.200304724 – ident: e_1_2_6_14_2 doi: 10.1039/c0sc00175a – ident: e_1_2_6_1_2 doi: 10.1039/b905798f – ident: e_1_2_6_10_2 doi: 10.1002/asia.200800149 – ident: e_1_2_6_21_2 doi: 10.1084/jem.182.5.1545 – ident: e_1_2_6_24_2 doi: 10.1016/j.jinorgbio.2010.05.002 – ident: e_1_2_6_4_2 doi: 10.1021/ic50211a024 – ident: e_1_2_6_22_2 doi: 10.1146/annurev.biochem.68.1.383 – ident: e_1_2_6_28_2 doi: 10.1016/S0022-328X(97)00776-6 – ident: e_1_2_6_6_2 doi: 10.1039/B712656P – ident: e_1_2_6_2_2 doi: 10.1039/b508531b – ident: e_1_2_6_3_2 doi: 10.1039/b904071d – ident: e_1_2_6_19_2 doi: 10.1016/j.drup.2006.05.002 – ident: e_1_2_6_8_2 doi: 10.1046/j.1432-1327.2000.01121.x – ident: e_1_2_6_20_2 doi: 10.1016/j.molmed.2006.07.007 – ident: e_1_2_6_25_2 doi: 10.1016/j.jinorgbio.2006.02.013 |
SSID | ssj0044818 |
Score | 2.113197 |
Snippet | Herein we describe the synthesis, characterization, and anticancer activity of novel p‐cymeneruthenium(II) complexes containing methyl, ethyl, n‐propyl, and... Herein we describe the synthesis, characterization, and anticancer activity of novel p-cymeneruthenium(II) complexes containing methyl, ethyl, n-propyl, and... Abstract Herein we describe the synthesis, characterization, and anticancer activity of novel p ‐cymeneruthenium(II) complexes containing methyl, ethyl, n... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1884 |
SubjectTerms | Antineoplastic Agents - chemical synthesis Antineoplastic Agents - pharmacology apoptosis Apoptosis - drug effects cancer Cell Line, Tumor Coordination Complexes - chemical synthesis Coordination Complexes - pharmacology Ethylenediamines - chemistry Humans leukemia Ligands mitochondrial depolarization Neoplasms - drug therapy ruthenium Ruthenium - chemistry Stereoisomerism Structure-Activity Relationship |
Title | Synthesis and in vitro Anticancer Activity of Ruthenium-Cymene Complexes with Cyclohexyl-Functionalized Ethylenediamine-N,N′-diacetate-Type Ligands |
URI | https://api.istex.fr/ark:/67375/WNG-JR8VJ9LK-J/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcmdc.201100232 https://www.ncbi.nlm.nih.gov/pubmed/21805645 https://search.proquest.com/docview/895855772 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hsmHDo7xMSzULFDZx68f4tYzchiq0UVVa6G409oyL1cRGcYLirrJhj9Qv6C_wSfkS7rVrhyAkJNjZI9uasc99-t4zhLwBo-la0rT1yDSUzoTw9IjJQE-k6ykzFtIJsMH5eOgenrPBhXPxSxd_zQ_RJtxQMip9jQIuomJvRRoaj2VcUXCi2UElbNoe1nTtn7b8URB6VAk-03cNHeKWoGFtNKy99dvXrNJ9fMHzP7mc6x5sZYL6j4hoJl9XnlztzqbRbnz9G6_j_6zuMXl455_SXg2oJ-SeyjZJ56QmuC679GzVr1V0aYeerKivy6fk9kOZgUdZpAUVmaRptlx8-5pOJzntZZg0B4RNaC-ud6ygeUKrAvssnY2Xi5uwHIPipaihRmquCoo5YhqW8Sj_rOblaLn43gcrXCcv02sl6QGgDKwmNr-MYcVwwbA7XC5-wAEMxVhJiYMYa9Oj9BK7mp-R8_7BWXio320Coce2CYGy60PIY8nIwh_AynMCh0khfNdJFJMJOCOOIW2lfCYkYxbSd_ngQ_mBoQyfSWnYz8lGlmfqJaGxKT1DJMIUFu7SFQgAKSgsIaPIRhpBjbxtQMC_1FwfvGZ1tjh-D95-D410Koy0l4nJFVbIeQ7_NHzHB6f-x0Fw9J4PNEIbEHGQW_wZIzKVzwruBxCoORDbaORFDa72YeB1GUjyoxGrgshfJsPD4_2wPXv1LzdtkQdWU9vItsnGdDJTr8HZmkY7lUD9BJ0FKa4 |
link.rule.ids | 315,783,787,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hdgEb3g_znAUKm7j1-7GM3IaQJlZVUmA3GnvGYDWxUZyguKts2CPxBfwCn5Qv4V67dhSEhAQ72_JYHs-5T997hpCXYDQdQ-imGumaVC3OXTWyhK8mwnGlHnNh-9jgPA6dwbk1_GA31YTYC1PzQ7QJN5SMSl-jgGNC-nDLGhrPRFxxcKLdAS28DzJv4iYGR2ctgxQEH1WKT_ccTYXIxW94GzXjcHf8jl3ax0-8-pPTuevDVkaof4tEzevXtScXB8tFdBBf_sbs-F_zu01uXrmotFdj6g65JrO7pHNac1yXXTrZtmwVXdqhp1v26_Ie-fG2zMCpLNKC8kzQNNusv35JF_Oc9jLMmwPI5rQX15tW0DyhVY19li5nm_X3oJyB7qWopKZyJQuKaWIalPE0_yRX5XSz_tYHQ1znL9NLKegxAA0MJ_a_zGDKcEPYDTfrn3AAl2IspsSLGG7TUfoRG5vvk_P-8SQYqFf7QKixqUOs7HgQ9RgiMvAfsHRt37YE555jJ9ISCfgjtiZMKT2LC8sykMHLAzfK8zWpeZYQmvmA7GV5Jh8RGuvC1XjCdW7gRl0-B5yCzuIiikxkElTIqwYF7HNN98FqYmeD4Xqwdj0U0qlA0t7G5xdYJOfa7H34mg3PvHdDf3TChgqhDYoYiC7-j-GZzJcF83yI1WwIbxTysEZX-zBwvDTk-VGIUWHkLy_DgvFR0J49_pdBL8j1wWQ8YqM34ckTcsNoSh2tp2RvMV_KZ-B7LaLnlXT9AgR4Lcg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtNAFB2hVkJsoDwbymMWKGzi1o_xaxk5DSVNo6i00N1o7BmD1cSp4gTFXWXDHokv4Bf4pHwJ99q1QxASEuzskW3N2Oc-fe8ZQl6B0XRMaVhaaOhKY0K4Wsikr8XScZURCWn72OB8MnCOzlnvwr74pYu_5IeoE24oGYW-RgG_kvHBmjQ0GsuooOBEswNKeJs5lo5FXZ3TmkAKYo8iw2d4jq5B4OJXtI26ebB5_4ZZ2sY3vPiTz7npwhY2qHuPiGr2ZenJ5f58Fu5H178RO_7P8nbI3RsHlbZLRN0nt1T6gDSHJcN13qJn64atrEWbdLjmvs4fku_v8hRcyizJqEglTdLV8svnZDad0HaKWXOA2JS2o3LLCjqJaVFhnybz8Wr5LcjHoHkpqqiRWqiMYpKYBnk0mnxSi3y0Wn7tghkus5fJtZL0EGAGZhO7X8awYrhg0Bqslj_gAIYiLKXEQQy2aT_5iG3Nj8h59_AsONJudoHQIsuASNnxIOYxZWjiH2Dl2r7NpBCeY8eKyRi8EVuXllIeE5IxE_m7PHCiPF9Xusek1K3HZCudpGqX0MiQri5iYQgTt-nyBaAUNJaQYWghj2CDvK5AwK9Ksg9e0jqbHL8Hr79HgzQLjNSXiekllsi5Nv8weMN7p977nt8_5r0GoRWIOAgu_o0RqZrMM-75EKnZENw0yJMSXPXDwO3SkeWnQcwCIn-ZDA9OOkF99vRfbnpJbg87Xd5_OzjeI3fMqs6RPSNbs-lcPQfHaxa-KGTrJ2lMLHc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+in+vitro+anticancer+activity+of+ruthenium-cymene+complexes+with+cyclohexyl-functionalized+ethylenediamine-N%2CN%27-diacetate-type+ligands&rft.jtitle=ChemMedChem&rft.au=Savi%C4%87%2C+Aleksandar&rft.au=Dulovi%C4%87%2C+Marija&rft.au=Poljarevi%C4%87%2C+Jelena+M&rft.au=Misirli%C4%87-Den%C4%8Di%C4%87%2C+Sonja&rft.date=2011-10-04&rft.eissn=1860-7187&rft.volume=6&rft.issue=10&rft.spage=1884&rft.epage=1891&rft_id=info:doi/10.1002%2Fcmdc.201100232&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1860-7179&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1860-7179&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1860-7179&client=summon |